1,806
Views
28
CrossRef citations to date
0
Altmetric
Original Articles

Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: A retrospective pilot study

, , , , , , & show all
Pages 180-186 | Received 17 Jun 2015, Accepted 26 Sep 2015, Published online: 25 Nov 2015

References

  • Cannata-Andía JB, Fernández-Martín JL, Zoccali C, London GM, Locatelli F, Ketteler M, et al. Current management of secondary hyperparathyroidism: A multicenter observational study (COSMOS). J Nephrol 2008;21:290–8
  • He Q, Zhuang D, Zheng L, Fan Z, Zhou P, Zhu J, et al. Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: A single-center experience. BMC Surg 2014;14:26
  • Sarfati E, Drueke TB. Surgical management of secondary hyperparathyroidism. In: Olgaard K, Silver J, Salusky IB, eds. The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease, 2nd ed. Oxford: Oxford University Press, 2010, pp. 543–59
  • Kidney Disease-Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease – mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009;113:S1–130
  • Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery. 2005;139:174–80
  • Simental A, Ferris RL. Reoperative parathyroidectomy. Otolaryngol Clin N Am 2008;41:1269–74
  • Yen TW, Wang TS, Doffek KM, Krzywda EA, Wilson SD. Reoperative parathyroidectomy: An algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery 2008;144:611–21
  • Fletcher S, Kanagasundaram NS, Rayner HC, Irving HC, Fowler RC, Brownjohn AM. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant 1998;13:1311–17
  • Giangrande A, Castiglioni A, Solbiati L, Allaria P. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant 1992;7:412–21
  • Kakuta T, Fukagawa M, Fujisaki T, Hida M, Suzuki H, Sakai H. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 1999;33:109–19
  • Chen HH, Lin CJ, Wu CJ, Lai CT, Lin J, Cheng SP, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg 2011;253:786–90
  • Nakamura M, Fuchinoue S, Teraoka S. Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism. Am J Kidney Dis 2003;42:739–45
  • Douthat WG, Orozco SE, de Arteaga J, Massari PU. Treatment of refractory secondary hyperparathyroidism with ethanol injection: The importance of glandular volume. Kidney Int 2003;63(Suppl 85):S101–4
  • Wang R, Jiang T, Chen Z, Chen J. Regression of calcinosis following treatment with radiofrequency thermoablation for severe secondary hyperparathyroidism in a hemodialysis patient. Intern Med 2013;52:583–7
  • Carrafiello G, Laganà D, Mangini M, Dionigi G, Rovera F, Carcano G, et al. Treatment of secondary hyperparathyroidism with ultrasonographically guided percutaneous radiofrequency thermoablation. Surg Laparosc Endosc Percutan Tech 2006;16:112–16
  • Andrioli M, Riganti F, Pacella CM, Valcavi R. Long-term effectiveness of ultrasound-guided laser ablation of hyperfunctioning parathyroid adenomas: Present and future perspectives. Am J Roentgenol 2012;199:1164–8
  • Kovatcheva RD, Vlahov JD, Stoinov JI, Kirilov GG, Krivoshiev SG, Arnaud F, et al. High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism. Nephrol Dial Transplant 2012;27:76–80
  • Yang YL, Chen CZ, Zhang XH. Microwave ablation of benign thyroid nodules. Future Oncol 2014;10:1007–14
  • Feng B, Liang P, Cheng Z, Yu X, Yu J, Han Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: Experimental and clinical studies. Eur J Endocrinol 2012;166:1031–7
  • Noussios G, Anagnostis P, Natsis K. Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp Clin Endocrinol Diabetes 2012;120:604–10
  • Roy M, Mazeh H, Chen H, Sippel RS. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg 2013;37:102–6
  • Kim HS, Choi BH, Park JR, Hahm JR, Jung JH, Kim SK, et al. Delayed surgery for parathyroid adenoma misdiagnosed as a thyroid nodule and treated with radiofrequency ablation. Endocrinol Metab (Seoul) 2013;28:231–5
  • Yang J, Hao R, Yuan L, Li C, Yan J, Zhen L. Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism. Am J Roentgenol 2014;202:180–4
  • Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 2006;244:296–304
  • Machi J. Radiofrequency ablation for hyperparathyroidism: Can it be a new treatment? Surg Laparosc Endosc Percutan Tech 2006;16:116
  • Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003;14(9/2):S199–202
  • Henry JF. Reoperation for primary hyperparathyroidism: Tips and tricks. Langenbecks Arch Surg 2010;395:103–9
  • Zitt E, Rix M, Ureña Torres P, Fouque D, Jacobson SH, Pétavy F, et al. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: Results of the ECHO study. Nephrol Dial Transplant 2011;26:1956–61
  • Stracke S, Keller F, Steinbach G, Henne-Bruns D, Wuerl P. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism. Nephron Clin Pract 2009;111:c102–9
  • Nawrot I, Chudziński W, Ciąćka T, Barczyński M, Szmidt J. Reoperations for persistent or recurrent primary hyperparathyroidism: Results of a retrospective cohort study at a tertiary referral center. Med Sci Monit 2014;20:1604–12
  • Wells SA Jr, Debenedetti MK, Doherty GM. Recurrent or persistent hyperparathyroidism. J Bone Miner Res 2002;17:N158–62
  • Singh Ospina N, Thompson GB, Lee RA, Reading CC, Young WF Jr. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2015;100:E87–90
  • Lu HI, Chou FF, Chi SY, Huang SC. Thoracoscopic removal of hypertrophic mediastinal parathyroid glands in recurrent secondary hyperparathyroidism. World J Surg 2015;39:400–9
  • Alesina PF, Moka D, Mahlstedt J, Walz MK. Thoracoscopic removal of mediastinal hyperfunctioning parathyroid glands: Personal experience and review of the literature. World J Surg 2008;32:224–31
  • Ravipati NB, McLemore EC, Schlinkert RT, Argueta R. Anterior mediastinotomy for parathroidecotmy. Am J Surg 2008; 195:799–802
  • Karakas E, Müller HH, Schlosshauer T, Rothmund M, Bartsch DK. Reoperations for primary hyperparathyroidism – improvement of outcome over two decades. Langenbecks Arch Surg 2013;398: 99–106
  • Yue W, Chen L, Wang S, Yu S. Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: A prospective study. Int J Hyperthermia 2015;31:403–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.